Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy

View source ↗

Summary

A clinical trial update examining the effects of topical Rho-kinase inhibitors on the cornea of patients with Fuchs Endothelial Corneal Dystrophy, including tho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Rho-kinase inhibitors

Snippet

Sponsor: University Hospital Dubrava | Conditions: Fuchs Endothelial Corneal Dystrophy, Cataract | Status: ENROLLING_BY_INVITATION